Susquehanna International Group, LLP Pds Biotechnology Corp Transaction History
Susquehanna International Group, LLP
- $823 Billion
- Q3 2025
A detailed history of Susquehanna International Group, LLP transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 94,344 shares of PDSB stock, worth $80,192. This represents 0.0% of its overall portfolio holdings.
Number of Shares
94,344
Previous 13,407
603.69%
Holding current value
$80,192
Previous $17,000
470.59%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding PDSB
# of Institutions
54Shares Held
5.62MCall Options Held
247KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA1.9MShares$1.62 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$413,9210.0% of portfolio
-
Geode Capital Management, LLC Boston, MA482KShares$409,6990.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il386KShares$328,4650.0% of portfolio
-
Inspirion Wealth Advisors, LLC344KShares$292,7340.05% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $24.2M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...